Wedbush initiates HEMAB outperform
Wedbush initiates coverage of Hemab Therapeutics with an outperform rating, citing potential growth prospects. This may impact investor sentiment on the stock.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.